Discover
CDTX
Cidara Therapeutics, Inc.
221.38
2 x 156.95
2 x 282.00
bid
ask
+
0.06
0.03%
09:30 AM
| Ytd | 0.22% | |
| 1y | 725.74% |
221.25
day range
221.41
15.22
52 week range
221.42
| Open | 221.32 | Prev Close | 221.32 | Low | 221.25 | High | 221.41 | Mkt Cap | 5.61B |
| Vol | 0.00 | Avg Vol | 1.37M | EPS | -11.20 | P/E | -19.77 | Forward P/E | 5.75 |
| Beta | 1.52 | Short Ratio | 1.34 | Inst. Own | 103.89% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-06 | 50-d Avg | 187.66 | 200-d Avg | 84.67 | 1yr Est | 221.50 |
| Income Statement | |||
| Operating Expenses | 88.63M | ||
| Research and Development Expense | 35.53M | ||
| Selling, General and Administrative Expense | 8.10M | ||
| Operating Income | -88.63M | ||
| Net Income | -83.23M | ||
| Net Income Common Stock | -83.23M | ||
| Net Income Common Stock (USD) | -83.23M | ||
| Consolidated Income | -83.23M | ||
| Earnings per Basic Share | -3.10 | ||
| Earnings per Basic Share (USD) | -3.10 | ||
| Earnings per Diluted Share | -3.10 | ||
| Earning Before Interest & Taxes (EBIT) | -83.23M | ||
| Earning Before Interest & Taxes (USD) | -83.23M | ||
| Weighted Average Shares | 26.88M | ||
| Weighted Average Shares Diluted | 26.88M | ||
| Balance Sheet | |||
| Cash and Equivalents | 299.99M | ||
| Cash and Equivalents (USD) | 299.99M | ||
| Investments | 176.53M | ||
| Investments Current | 126.37M | ||
| Investments Non-Current | 50.16M | ||
| Trade and Non-Trade Receivables | 1.86M | ||
| Current Assets | 442.82M | ||
| Property, Plant & Equipment Net | 2.09M | ||
| Total Assets | 518.65M | ||
| Debt Current | 1.56M | ||
| Total Debt | 1.98M | ||
| Current Liabilities | 95.84M | ||
| Debt Non-Current | 424.00K | ||
| Total Liabilities | 96.26M | ||
| Accumulated Retained Earnings (Deficit) | -743.69M | ||
| Accumulated Other Comprehensive Income | -107.00K | ||
| Shareholders Equity | 422.39M | ||
| Shareholders Equity (USD) | 422.39M | ||
| Assets Non-Current | 75.83M | ||
| Total Debt (USD) | 1.98M | ||
| Liabilities Non-Current | 424.00K | ||
| Trade and Non-Trade Payables | 4.35M | ||
| Tax Liabilities | 15.07M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 354.00K | ||
| Net Cash Flow from Financing | 160.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -216.92M | ||
| Issuance (Purchase) of Equity Shares | 297.00K | ||
| Net Cash Flow from Investing | -176.47M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -176.47M | ||
| Net Cash Flow from Operations | -40.61M | ||
| Share Based Compensation | 3.17M | ||